Both in Pharmaceuticals
Xencor vs Prestige Consumer Healthcare
Over the past year XNCR returned +155.7% and PBH returned −12.0%; their daily moves had a correlation of 0.03.
XNCR +155.7% PBH −12.0%Growth of $1, one year, split-adjusted
| Metric | XNCR | PBH |
|---|---|---|
| Price | $35.03 | $53.28 |
| Market cap | $2.60B | $2.52B |
| Today | +14.33% | +7.55% |
| 1 month | +43.8% | +14.7% |
| 6 months | +169.3% | −1.9% |
| Year to date | +128.8% | −13.6% |
| 1 year | +151.3% | −12.1% |
| Revenue growth (YoY) | +17.5% | +6.5% |
| Gross margin | 100.0% | 51.3% |
| Net margin | −42.4% | 11.0% |
| P/E (TTM) | — | 14.7× |
| Price / sales | 24.8× | 2.3× |
| Net cash | $351.6M | -$1.95B |
| Dividend yield | — | — |
| Volatility (60d) | 67.2% | 33.5% |
| Short % of float | 17.0% | 8.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).